arrow
A

Aleš Linhart

Charles University and General University Hospital
H指数:81
被引数:10.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial

司美格鲁肽和心血管风险降低:SELECT试验的中介分析

2026-09-230
OAAI
Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients

α-半乳糖苷酶A活性、溶酶体Gb3和X染色体失活的参数化评估有助于法布雷病女性患者的基因型-表型分类

2026-06-220
OAAI
Sustained increases in physical activity after a walking intervention in heart failure: 12-month WATCHFUL trial results

心力衰竭患者步行干预后的持续性身体活动增加:12个月WATCHFUL试验结果

2025-11-120
OAAI
Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trial

西药多片复方策略与标准治疗在西班牙二级心血管预防中的成本效益分析:基于SECURE试验的分析

2025-06-270
PRE
Extending the interval between pegunigalsidase alfa infusions in patients with Fabry disease: Five-year interim results from the ongoing BRIGHT51 study
2025-02-010
PRE
Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases

糖尿病心肌疾病。ESC心力衰竭协会和ESC心肌和心包疾病工作组的临床共识声明

2024-06-196
PRE